Anti-Tat T cell receptor (c23), pCDTCR1(TCR-C243Z)
The vector of anti-Tat T cell receptor (TCR) is constructed for the engineering of T cell to target HIV-1 Tat. The T cells are genetically modified through transduction with a lentiviral vector expressing Tat-specific T cell receptor. And the vector product was designed for the treatment of HIV-1 infection.
Extracellular circulating Tat can be endocytosed by surrounding uninfected cells via the binding to several surface receptors such as CD26, CXCR4, heparan sulfate proteoglycans (HSPG) or LDLR. Neurons are rarely infected, but they internalize Tat via their LDLR. Through its interaction with nuclear HATs, Tat is potentially able to control the acetylation-dependent cellular gene expression. Modulates the expression of many cellular genes involved in cell survival, proliferation or in coding for cytokines or cytokine receptors. Tat plays a role in T-cell and neurons apoptosis. Tat induced neurotoxicity and apoptosis probably contribute to neuroAIDS.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.